Magellan Health (MGLN) has a profit margin of 7.28%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2021
Trailing 12 months ending Sep 2021
The latest profit margin for MGLN is 7.28% as of September 2021. That compares with 2.28% in the prior-year period — up 218.7% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Magellan Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, MGLN's profit margin moved from 2.28% to 7.28% — a 218.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Magellan Health's valuation or profitability profile.
Against Healthcare companies, MGLN currently prints 7.28% for profit margin, while the sector average sits near 14.34%. That is roughly 49.3% below the sector mean. Large gaps often invite a closer look at Magellan Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Magellan Health converts resources into returns. At 7.28%, MGLN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.28% in the prior-year period — up 218.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MGLN's profit margin (7.28%), review year-over-year change from 2.28%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.